During the 2018 National Rare Disease Plan (PNMR3), the treatment center at the Caen Normandy University Hospital was renewed as a constituent site of the Willebrand Disease Reference Center (CRMW).
Team
- University Professor · Hospital Practitioner
- Hospital Practitioner
- Medical Secretary
- Coordinating Nurse
- ARC Investigator
- Laboratory Technician
- Contractual Practitioner
- PHcMedical Biology
Activity
SupportThe Centre for the Treatment of Hemorrhagic Diseases at the Caen Normandy University Hospital (CRTH) provides comprehensive care for people with hemorrhagic diseases.
The Caen center provides comprehensive care for people with von Willebrand disease:
- Clinical and biological diagnosis
- Clinical and biological monitoring
- Therapeutic Education Activities
- Drafting treatment protocols
The Caen center also provides training and teaching activities on Willebrand disease and clinical and basic research activities (therapeutic trials, PHRC…).